Retatrutide is not yet FDA approved, but like many GLP-1 agonists such as Wegovy (semaglutide) and Mounjaro (tirzepatide), retatrutide will most likely be a weekly injection, delivered subcutaneously into the arm, thigh or stomach area in a self-inject pen
Complete retatrutide reconstitution chart: 20mg vial The 20mg vial becomes essential once your dose escalation moves past 4mg weekly
The Lancet trial ran 26 weeks
Follow the titration schedule : Slow, gradual dose increases give your body time to adapt to each level of weight loss
Contact your doctor if you notice persistent pain, spreading redness, warmth or pus at the injection site, signs of allergic reaction, or if youre unsure about a dosing error
And they can eliminate sleep apnea, can help curb cravings for alcohol and drugs and show great promise in reducing cancer risks